Royal Bank of Canada’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $9.55M | Buy |
|
|||||
|
2025
Q2 | $4.82M | Sell |
|
|||||
|
2025
Q1 | $5.42M | Sell |
|
|||||
|
2024
Q4 | $4.18M | Sell |
|
|||||
|
2024
Q3 | $3.53M | Buy |
|
|||||
|
2024
Q2 | $6.11M | Buy |
|
|||||
|
2024
Q1 | $742K | Sell |
|
|||||
|
2023
Q4 | $1.3M | Buy |
|
|||||
|
2023
Q3 | $951K | Buy |
|
|||||
|
2023
Q2 | $1.1M | Buy |
|
|||||
|
2023
Q1 | $510K | Sell |
|
|||||
|
2022
Q4 | $549K | Buy |
|
|||||
|
2022
Q3 | $396K | Sell |
|
|||||
|
2022
Q2 | $2.03M | Buy |
|
|||||
|
2022
Q1 | $2.65M | Buy |
|
|||||
|
2021
Q4 | $1.28M | Buy |
|
|||||
|
2021
Q3 | $996K | Buy |
|
|||||
|
2021
Q2 | $886K | Buy |
|
|||||
|
2021
Q1 | $727K | Sell |
|
|||||
|
2020
Q4 | $1.34M | Buy |
|
|||||
|
2020
Q3 | $426K | Sell |
|
|||||
|
2020
Q2 | $1.18M | Buy |
|
|||||
|
2020
Q1 | $736K | Buy |
|
|||||
|
2019
Q4 | $571K | Sell |
|
|||||
|
2019
Q3 | $551K | Sell |
|
|||||
|
2019
Q2 | $1.26M | Buy |
|
|||||
|
2019
Q1 | $655K | Sell |
|
|||||
|
2018
Q4 | $1.52M | Buy |
|
|||||
|
2018
Q3 | $837K | Sell |
|
|||||
|
2018
Q2 | $605K | Sell |
|
|||||
|
2018
Q1 | $825K | Buy |
|
|||||
|
2017
Q4 | $626K | Sell |
|
|||||
|
2017
Q3 | $15.3M | Buy |
|
|||||
|
2017
Q2 | $16.3M | Buy |
|
|||||
|
2017
Q1 | $12.9M | Sell |
|
|||||
|
2016
Q4 | $10.8M | Sell |
|
|||||
|
2016
Q3 | $12.7M | Buy |
|
|||||
|
2016
Q2 | $5.1M | Buy |
|
|||||
|
2016
Q1 | $2.54M | Buy |
|
|||||
|
2015
Q4 | $156K | Sell |
|
|||||
|
2015
Q3 | $177K | Buy |
|
|||||
|
2015
Q2 | $116K | Buy |
|
|||||
|
2015
Q1 | $75K | Buy |
|
|||||
|
2014
Q4 | $54K | Sell |
|
|||||
|
2014
Q3 | $64K | Buy |
|
|||||
|
2014
Q2 | $32K | Sell |
|
|||||
|
2014
Q1 | $163K | Buy |
|
|||||
|
2013
Q4 | $17K | Buy |
|
|||||
|
2013
Q3 | $10K | Hold |
|
|||||
|
2013
Q2 | $6K | Buy |
|